In Fischer rats infected with Japanese encephalitis virus (JEV) at 13 days after birth and sacrificed 12 weeks later, the major pathological changes resembled those found in Parkinson's disease. Specifically there was neuronal loss with gliosis which was confined mainly to the zona compacta of the substantia nigra, with a notable absence of lesions in the cerebral cortex and cerebellum. Changes were bilateral being most severe in the central part of the zona compacta. Immunohistochemical studies with anti-tyrosine hydroxylase (TH) demonstrated that the number of TH-positive neurons was significantly decreased in the substantia nigra compared to controls, while comparable numbers of TH-positive neurons were found in the basal ganglia in both JEVtreated rats and age-matched controls. JEV-infected rats showed marked bradykinesia, with significant behavioral improvement being observed following administration of L-DOPA. Immunohistochemical studies failed to detect JEV antigens in any region of the rat brain and the JEV genome was undetectable in the substantia nigra and the cerebral cortex using the reverse transcription-polymerase chain reaction (RT ± PCR). The findings suggest that JEV infection of rats under the conditions described may serve as a model of virus induced Parkinson's Disease.
Introduction
The development of experimental models of Parkinson's Disease have in most instances involved the administration of drugs or following acute viral infections. The most widely used model is that induced by the metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Burns et al, 1983; Ballard et al, 1985) . Neuropathologic findings in MPTP-treated monkeys are similar to those of Parkinson's disease in that neurons in the substantia nigra are primarily involved, while other structures of the basal ganglia are spared. Despite these similarities, MPTP-induced parkinsonism does differ from the human disease in several respects Ballard et al, 1985; Langston, 1989) and the model is limited in that disease is induced only minimally or not at all in small animal species, including rats Heikkila et al, 1984) . A second drug associated model of parkinsonism, which involves the stereotactic injection of 6-hydroxydopamine into the substantia nigra, is severely limited by technical difficulties (Kelly et al, 1975) . Virusinduced models of Parkinson's disease have been reported following infection with both corona-virus (Fishman et al, 1985) and influenza virus (Takahashi et al, 1995) . In this report we describe the development of pathological and certain clinical features consistent with Parkinson's disease following inoculation of Japanese encephalitis virus (JEV). We have previously described the pathological features and distribution of JEV antigens in developing rat brain after intracerebral virus inoculation (Ogata et al, 1991) . In these studies it could be shown that in general the susceptibility of rat brain to JEV infection was dependent on the age of animals at the time of infection and this appeared to be related to the level of neuronal maturity. Of note it could be shown that neurons of basal ganglia and substantia nigra remained much more susceptible to infection than those of the cerebral cortex (Ogata et al, 1991) . Specifically animals infected at 1 ± 3 days of age developed widespread infection throughout the brain, whereas in animals infected at age 10 days, JEV antigen became almost undetectable in the cerebral cortex and by 14-day-old rats JEV antigen was essentially restricted to the basal ganglia and substantia nigra (Ogata et al, 1991) . The limitation of infection to these areas suggested that infection of rats between days 12 and 14 after birth may result in pathological and clinical processes which might resemble Parkinson's disease. In the present study we describe the pathological and virological features of such infections and show that this in fact does serve as a useful model of Parkinson's disease.
Results

Neuropathologic studies
In control studies, 13-day-old animals infected with JEV were sacrificed 3 days later and JEV antigen was found primarily in the substantia nigra and the caudate putamen in a distribution similar to that previously described (Ogata et al, 1991) . Strikingly the expression of JEV antigen was localized to neurons in the substantia nigra (Figure 1, arrows) . In contrast, JEV antigen could not be detected in brains of the rats sacrificed at 10 days, 12 weeks and one year after infection. Pathological examination showed that in adult rats infected with JEV at the age of 13 days, neuronal loss was confined mainly to the zona compacta of the substantia nigra. No lesions were observed in the cerebral cortex or cerebellum (Figure 2a and b) . Furthermore, the most severe lesions were found in the central part of the zona compacta, with the lateral cell groups being less affected (Figure 2a and b) . In the infected rats, the neuronal loss was also associated with marked gliosis in the zona compacta region (Figure 2c ) compared to control animals ( Figure 2d ). Immunohistochemical analysis with anti-tyrosine hydroxylase (TH) antibody showed that the number of THpositive neurons was also significantly less in the substantia nigra (Figure 3a ) compared to that in controls (Figure 3c ). However, equivalent numbers of TH-positive neurons were found in the caudate putamen in JEV-infected rats (Figure 3b ) as well as in age-matched control rats (Figure 3d ). These pathologic findings suggest there is a selective vulnerability of neurons of the substantia nigra and to a lesser extent caudate putamen of rats to the destructive effects of JEV following intracerebral inoculation. In the JEV-infected rat brains, the same pathologic features were found in greater than 80% of the animals examined (25/30). Moreover in rats sacrificed 1 year after JEV inoculation, almost no TH-positive neurons could be found in the substantia nigra (data not shown). The latter observation might suggest that the dopaminergic system function may deteriorate even further with age. Although no Lewy bodies or locus ceruleus lesions were observed, and immunohistochemical staining with an ant-tau antibody was negative (unpublished data), the distribution of the pathological lesions in the substantia nigra found in JEV-treated rats was remarkably similar to that in Parkinson's disease.
Tissue distribution of the JEV genome by RT ± PCR Using RT ± PCR and cerebral cortex tissue samples from rats infected with JEV at age 5 days and sacrificed 5 days later, JEV genomic RNA could be readily detected under the conditions employed ( Figure 4 , lane 1). Similarly in rats infected with JEV at age 13 days, the cerebral cortex (lane 2) and the substantia nigra (lane 3) taken from the rats sacrificed 5 days later also contained JEV genomic RNA. In both the negative controls (not shown) and the cerebral cortex (lane 4) where no abnormal neuropathologic changes could be found, JEV RNA was not detected. Despite the histopathological changes JEV genome was also not detected in the substantia nigra (lane 5). These results suggest that there was no persistent infection by JEV in these tissues. In these studies only one primer pair was used for detection of genomic RNA. As the JEV genome is a single stranded RNA molecule the employment of additional primers would not be expected to produce different findings from those just described.
Motor function
The motor activity of the adult rats infected with JEV at age 13 days, was tested 12 weeks later and compared to age-matched control rats. The time required for the pole test was 18.3+4.3 s (n=10) for the JEV-infected rats before L-DOPA treatment, Figure 1 Immunohistochemical staining with anti-Japanese encephalitis virus (JEV) antibody in the midbrain of a rat sacrificed 3 days after JEV infection at the age of 13 days (6100). Photomicrograph of a coronal section through the brain of the rat shows dense accumulation of JEV antigen in the neurons of the substantia nigra (arrows). cp, cerebral peduncle; SN, substantia nigra.
6.5+1.4 s (n=14) for the control rats, and 8.3+2.6 s (n=10) for the JEV-infected rats after treatment with L-DOPA. The difference between the JEV-infected rats and the control rats was significantly (P50.001, Figure 5 ). The pole test results are consistent with marked bradykinesia observed in the JEV-infected affected rats. Unfortunately other clinical features seen in human disease such as masked facies or tremor could not be assessed in the infected animals.
Discussion
The pathogenesis of Parkinson's disease is poorly understood but is almost certainly multifactorial involving genetic, environmental and possibly infectious components (Calne and Langston, 1983; Burns et al, 1983; Ballard et al, 1985; Cohen, 1986; Riederer et al, 1989; Dexter et al, 1989; Adams and Odunze, 1991; Nagatsu and Yoshida, 1988; Yoshida et al, 1990) . With regard to the latter, a number of viruses have been shown to selectively infect the substantia nigra and induce parkinsonism (Kristensson, 1992; Duvoisin and Yahr, 1965) . Postencephalitic parkinsonism has been well documented (von Economo, 1917; Yahr, 1978) and the world pandemic of encephalitis lethargica, von Economo encephalitis, from 1916 to 1927 resulted in the death or disability of approximately half a million people. In addition there have been individual case reports describing the association of different viruses with this disorder. These have included a 54-year-old woman who manifested symptoms of parkinsonism while convalescing from meningoencephalitis due to Coxsackie B virus (Walters, 1960) and similar processes have been described following influenza A (Hudson and Rice, 1990) , poliovirus (Bojinov 1971) and measles virus (Alves et al, 1992) infections. The possible involvement of virus infection has also been supported by experimental animal models, Fishman et al. (1985) reported a selective attack on the substantia nigra and subthalamic nucleus by a strain of mouse hepatitis virus, and more recently similar features have been described in rats infected with influenza virus (Takahashi et al, 1995) . In the present study we have demonstrated pathological and to a certain extent clinical features consistent with Parkinson's disease following infection of rats with JEV. The JEV induced parkinsonism in rats is characterized by selective destruction of neurons in the substantia nigra, bilaterally, and particularly in the region of the zona compacta with an associated loss of TH producing cells in this region. Attempts to detect JEV using immunohistochemistry or by RT ± PCR to amplify the NS3 region of the JEV genome showed that genomic RNA could not be detected in affected rats sacrificed 12 weeks after initial infection. In contrast reactions under identical conditions on control samples readily allowed the detection of genome in control tissues. These findings suggest that in our animal model there does not appear to be a persistent or chronic JEV infection. The immunohistochemical data obtained also suggested that the function of the dopaminergic system may progressively deteriorate with age in the absence of ongoing or persistent JEV infection.
McGeer et al (1988) showed that the rate of neuronal cell degeneration was considerably higher in Parkinsonian patients than could be accounted for on the basis of normal age-related neuronal degeneration alone. It seems that neuronal cell degeneration in our model may also have progressed more rapidly in the JEV-treated rats than in the controls. This observation raises the possibility that postencephalitic parkinsonism as well as Parkinson's disease could be a continuing degenerative process rather than an acute illness on which the effects of aging or decompensation are superimposed (Gibb and Lees, 1987; Geddes et al, 1993) .
JEV infection is the most common cause of arthropod-borne human encephalitis worldwide, and infection has also been associated with postencephalitis parkinsonism syndrome in man (Goto, 1962; Dickerson et al, 1952; Richter and Shimojyo, 1916; Shoji et al, 1993) . Dickerson et al (1952) , in a study of 200 acute cases of Japanese encephalitis, noted tremors primarily involving the fingers, tongue and eyelids in 90%, muscular rigidity in greater than 40%, and a mask-like face is in 75% of a b c d Figure 3 Immunohistochemical study of the substantia nigra and caudate-putamen with anti-tyrosine hydroxylase (TH) antibody in JEV-infected rat (a, b640) sacrificed 12 weeks after JEV infection at the age of 13 days and an age-matched control rat (c,d640). THpositive neurons in JEV-infected rats (a) are decreased in number in the substantia nigra compared with those in a control rat (c), whereas numerous TH-positive neurons are found in the caudate putamen in JEV-infected rats (b) as well as a control rat (d). C, cerebral cortex; CPu, caudate putamen; cp, cerebral peduncle; R, red nucleus; SNc, substantia nigra zona compacta; SNr, substantia nigra zona reticulata.
the cases. Goto (1962) detected parkinsonian sequelae in 11.6% of 143 unselected patients 5 years after they had Japanese virus encephalitis. The parkinsonian syndrome following Japanese encephalitis appears to differ from that following encephalitis lethargica in several respects. In general, parkinsonism after Japanese encephalitis is mild, develops in the acute phase, and occasionally improves slightly over a long period. However these clinical observations together with our rat model might suggest the involvement of JEV in certain cases. It remains unclear why the neurons of the substantia nigra remain susceptible to JEV infection as opposed to other regions of the brain (Ogata et al, 1991; Kimura-Kuroda et al, 1993) . One possibility is that virus receptors on the substantia nigra neurons persist longer than in other CNS structures. Certainly, the capacity of viruses to attack specific tissues selectively depends on an interaction between viral genes or proteins and host factors. Immune mechanisms (Appel et al, 1992) following an infection or other factors could also be associated with the destruction of the substantia nigra. Further studies on the tropism of JEV for the substantia nigra in this experimental model might reveal mechanisms that are involved in the degeneration of nigral dopaminergic neurons that is central to this disease.
Finally, although it was difficult to assess the clinical status of our infected animals significant behavioral improvement was observed upon administration of L-DOPA. The pole test employed in these studies appears to be useful in assessing clinical status and response to therapy. Accordingly, this JEV-induced parkinsonian model might be important not only in studies of the pathogenesis of this disease but possibly useful in the assessment of new anti-parkinsonian drugs, and perhaps in the efficiency of neuronal transplantation therapy.
Materials and methods
Animals and virus
Albino rats of the Fischer strain were obtained from SLC Japan. The virus strain used was the JaGAr-01 strain of JEV. Supernatants from 10% homogenates of infected mouse brains (10 9 PFU/ml) were diluted with 20% Hemacel (Hoechst) in Eagle's minimum essential medium and stored at 7708C until use. Virus (0.03 ml containing 3610 6 PFU) was inoculated intracerebrally with a specially designed twostep thin 27 gauge needle (Hoshimori Iryoki KK, Tokyo, Japan) with a stopper 3 mm from the tip. The site of inoculation was located at the midpoint of the line connecting the left eye to the midpoint between the right and left ears. Hemacel (20%) in Eagle's minimum essential medium was injected into control rats. 
Neuropathologic studies
The neuropathologic changes in rats infected with JEV on days 12, 13 and 14 after birth were examined. In each case animals were sacrificed at 3 days, 10 days, 12 weeks or 1 year after inoculation under ether anesthesia by perfusion fixation via the aorta with 4% freshly prepared paraformaldehyde in 0.1 M phosphate buffer. Coronal brain sections were taken from the frontal tip to the medulla, embedded in paraffin, and stained with hematoxylin-eosin, Luxol fast blue-cresyl violet (Klu È verBarrera method), anti-JEV antibody and anti-tyrosine hydroxylase (TH) monoclonal antibody (Chemicon). The avidin-biotin-peroxidase complex (ABC) method was used in all immunohistochemical studies (Hsu et al, 1981) . After deparaffinization, the specimens were treated with 0.3% H 2 O 2 -methanol to suppress endogenous peroxidase activity, incubated with 10% normal goat serum, and allowed to react with anti-JEV rabbit serum or anti-TH monoclonal antibody, diluted in 1% bovine serum albumin (BSA) at 48C overnight. Incubations with only 1% BSA were used as negative controls. The sections reacted with anti-JEV antibody and anti-TH monoclonal antibody were reacted with biotinylated goat anti-rabbit IgG and biotinylated goat anti-mouse IgG respectively. ABC reaction products were visualized with 3,3'-diaminobenzidine tetrahydrochloride (Sigma) and counterstained with hematoxylin.
Reverse transcription-polymerase chain reaction (RT ± PCR) Primers used in RT ± PCRs were 5739 -5'-AGA-GCGGGGAAAAAGGTCAT-3'-5758 (sense) and 5900-3'-TTTCACGCTCTTTCTACAGT-5'-5881 (antisense) which permitted amplification of the NS3 region of the JEV genome (Sumiyoshi et al, 1987) . Oligonucleotides were synthesized on a Cyclone Plus DNA/RNA synthesizer (Millipore Co., Japan). Prior neuropathological and immunohistochemical studies (Ogata et al, 1991) demonstrated that rats infected with JEV on days 5 after birth had a severe panencephalitis with readily detectable JEV antigen. Thus, brains taken from 3 rats inoculated with JEV on days 5 after birth and sacrificed 5 days later were used as positive controls. Cerebral cortex taken from an uninfected normal rat brain was used as a negative control. Rats infected with JEV on day 13 of life were sacrificed at 5 days (3 rats) or 12 weeks (3 rats) later. Pieces of the cerebral cortex and the ventral region of the midbrain were taken from each animal using a magnifying microscope. In all 100 milligrams of brain tissue was added to 1 ml PBS and homogenized with a Polytron. 5 ml of this homogenate were then incubated with an equal volume of detergent mix (2% NP-40, 10 U of RNase inhibitor (Takara Co., Kyoto, Japan) in PBS) in a 500 ml Eppendorf-type tube for 1 min at room temperature. This was added to 90 ml of RT ± PCR mix (100 pmol of each primer, 0.2 mM deoxynucleoside triphosphate, 10 mM Tris (pH 8.9), 1.5 mM MgCl 2 , 80 mM KCl, 0.5 mg of BSA per ml, 0.1% sodium cholate, 0.1% Triton X-100, 10 U of reverse transcriptase (Takara Co., Kyoto, Japan) and 2 U of Th-DNA polymerase, a thermostable DNA polymerase (Toyobo Co., Osaka, Japan). The reaction mixture was incubated for 10 min at 538C for the RT reaction. PCR amplification (928C for 60 s, 538C for 90 s and 728C for 120 s using a PC-700 thermal cycler (Astec Co., Fukuoka, Japan) was started immediately after the RT step and continued for 35 cycles (Morita et al, 1991) . PCR products were separated on a 3% agarose gels and after electrophoresis were visualized by ethidium bromide staining. Amplification produced a 142 bp fragment.
Assessment of motor function
A pole test (Ogawa et al, 1985) was performed as a way of evaluating bradykinesia in the infected rats. The time for the rats to descend from the top of a rough-surfaced pole (2.5 cm in diameter and 100 cm in height) to the floor was recorded in JEVinfected adult rats and adult controls. To assess the efficiency of L-DOPA, the same procedure was repeated immediately after the successive intraperitoneal injection of L-DOPA (10 mg/kg/day) for 7 days. Comparisons among mean values for groups were done by Student's t test.
